All Stories

  1. The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation
  2. A short ERAP2 that binds IRAP is expressed in macrophages independently from gene variation
  3. The Multifaceted Nature of Aminopeptidases ERAP1, ERAP2, and LNPEP: From Evolution to Disease
  4. The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia
  5. EBV, CD8 and Ankylosing spondylitis
  6. Ankylosing Spondylitis: A Trade Off of HLA-B27, ERAP, and Pathogen Interconnections? Focus on Sardinia
  7. AIF-1 gene does not confer susceptibility to Behçet’s disease: Analysis of extended haplotypes in Sardinian population
  8. An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes
  9. Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis
  10. The Peptide Repertoire of HLA-B27 may include Ligands with Lysine at P2 Anchor Position
  11. HLA Class I or Class II and Disease Association: Catch the Difference If You Can
  12. The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis
  13. RNA editing signature during myeloid leukemia cell differentiation
  14. The Ankylosing Spondylitis-Associated HLA-B*2705 Presents a B*0702-Restricted EBV Epitope and Sustains the Clonal Amplification of Cytotoxic T Cells in Patients
  15. Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation
  16. Single Nucleotide Polymorphisms in the 3′UTR of VPAC-1 Cooperate in Modulating Gene Expression and Impact Differently on the Interaction with miR525-5p
  17. Reprint of “Genetics of autoimmunity: An update”
  18. The multifaceted nature of NLRP12
  19. Genetics of autoimmunity: An update
  20. HLA-B27 and antigen presentation: At the crossroads between immune defense and autoimmunity
  21. Characterization of a Proteasome and TAP-independent Presentation of Intracellular Epitopes by HLA-B27 Molecules
  22. Interaction Pattern of Arg 62 in the A-Pocket of Differentially Disease-Associated HLA-B27 Subtypes Suggests Distinct TCR Binding Modes
  23. Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time
  24. Gender-dependent association of type 2 diabetes with the vasoactive intestinal peptide receptor 1
  25. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
  26. Divergent Effect of Cobalt and Beryllium Salts on the Fate of Peripheral Blood Monocytes and T Lymphocytes
  27. The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p
  28. CD8+ T-cell mediated self-reactivity in HLA-B27 context as a consequence of dual peptide conformation
  29. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene
  30. The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: A unifying hypothesis
  31. HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia
  32. T-Cell Responses Against Viral and Self-Epitopes and HLA-B27 Subtypes Differentially Associated with Ankylosing Spondylitis
  33. A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B *2705 in Sardinia
  34. Citrullination-dependent Differential Presentation of a Self-peptide by HLA-B27 Subtypes
  35. HLA-B27 and Ankylosing Spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis
  36. HLA-B27 and ankylosing spondylitis geographic distribution versus malaria endemic: casual or causal liaison?
  37. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis
  38. A sardinian patient with ankylosing spondylitis and HLA–B*2709 co-occurring with HLA–B*1403
  39. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA–B27 extended haplotypes in sardinia
  40. The pathogenetic role of HLA-B27 and its subtypes
  41. Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis
  42. The C Terminus of the Nucleoprotein of Influenza A Virus Delivers Antigens Transduced by Tat to the trans-Golgi Network and Promotes an Efficient Presentation through HLA Class I
  43. Conformational Dimorphism of Self-peptides and Molecular Mimicry in a Disease-associated HLA-B27 Subtype
  44. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies
  45. Allele-dependent Similarity between Viral and Self-peptide Presentation by HLA-B27 Subtypes
  46. Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide
  47. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: Implications for disease pathogenesis
  48. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease
  49. T cell response to N-formylated peptides in humans
  50. HLA-DP Allele-Specific T Cell Responses to Beryllium Account for DP-Associated Susceptibility to Chronic Beryllium Disease
  51. Tolerance induction in indirect alloresponses by analogs of HLA-derived peptides
  52. CD8+ T-cell autoreactivity to an HLA-B27–restricted self-epitope correlates with ankylosing spondylitis
  53. HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease
  54. The naturally occurring polymorphism Asp116 → His116 , differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition
  55. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DPβ chain
  56. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B
  57. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes
  58. HLA-DPB1 MISMATCH AT POSITION 69 IS ASSOCIATED WITH HIGH HELPER T LYMPHOCYTE PRECURSOR FREQUENCIES IN UNRELATED BONE MARROW TRANSPLANT PAIRS1
  59. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis
  60. Ultrastructural allelic variation in HLA-DQB1 promoter elements
  61. The Asp116-His116 substitution in a novel HLA-B27 subtype influences the acceptance of the peptide C-terminal anchor
  62. Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I α chains
  63. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease
  64. HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides
  65. Strong genetic association between HLA-DR3 and a polymorphic variation in the regulatory region of the HSP70-1 gene
  66. A new approach to HLA-DPB1 typing combining DNA heteroduplex analysis with allele-specific amplification and enzyme restriction
  67. Probe-Less Genomic Typing of ARG52 (Type 1 Diabetes-Associated) and Non-Arg52 (Non-Type 1 Diabetes-Associated) HLA-DQA1 Alleles
  68. Subgrouping of DR4 alleles by DNA heteroduplex analysis
  69. Detection of complex alleles by direct analysis of DNA heteroduplexes
  70. Arg74 in HLA-DRBI and DRB3 controls a DR3-related epitope
  71. DNA typing of anHLA-DR bilocus specificity by gene amplification and oligonucleotide hybridization
  72. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules
  73. DNA restriction fragment length polymorphism of HLA-DR2: Correlation with HLA-DR2-associated functions
  74. Structural organization of the DR subregion of the human major histocompatibility complex.
  75. Genetic Complexity and Expression of Human Class II Histocompatibility Antigens
  76. Current view of the human Ia system based on serological and immunochemical analysis
  77. Microfingerprinting analysis of human Ia molecules favours a three loci model
  78. Human Ia molecules carrying DC1 or BR4X7 determinants are not homologous to murine I-E molecules
  79. Human Ia molecules carrying DC1 determinants differ in both α- and β-subunits from Ia molecules carrying DR determinants
  80. Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody
  81. Biochemical controls of the G1 phase of a mammalian cell cycle I. Analysis of chromatin proteins in temperature-sensitive variants
  82. Effect of cytosine arabinoside triphosphate on the incorporation of3H-thymidine in mitochondria isolated from HeLa cells
  83. Conditional expression of the transformed phenotype in an ?epithelial-like? cell line